nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Adenosine A2A receptor agonist (regadenoson) in human lung transplantation
|
Lau, Christine L. |
|
|
39 |
6 |
p. 563-570 |
artikel |
2 |
An extracellular oxygen carrier during prolonged pulmonary preservation improves post-transplant lung function
|
Ali, Aadil |
|
|
39 |
6 |
p. 595-603 |
artikel |
3 |
Big devices in small patients: Adapting adult ventricular assist devices for children
|
Conway, Jennifer |
|
|
39 |
6 |
p. 580-581 |
artikel |
4 |
COVID-19 and transplant research from China: An ethical dilemma
|
Rogers, Wendy A. |
|
|
39 |
6 |
p. 614-615 |
artikel |
5 |
COVID-19 in a lung transplant recipient
|
Aigner, Clemens |
|
|
39 |
6 |
p. 610-611 |
artikel |
6 |
COVID-19 pneumonia in a dual heart–kidney recipient
|
Stachel, Maxine W. |
|
|
39 |
6 |
p. 612-614 |
artikel |
7 |
Donor heart and lung procurement: A consensus statement
|
Copeland, Hannah |
|
|
39 |
6 |
p. 501-517 |
artikel |
8 |
Donor organ evaluation in the era of coronavirus disease 2019: A case of nosocomial infection
|
Patel, Krishan J. |
|
|
39 |
6 |
p. 611-612 |
artikel |
9 |
Early experience with the HeartMate 3 continuous-flow ventricular assist device in pediatric patients and patients with congenital heart disease: A multicenter registry analysis
|
O'Connor, Matthew J. |
|
|
39 |
6 |
p. 573-579 |
artikel |
10 |
Editorial Board
|
|
|
|
39 |
6 |
p. A1 |
artikel |
11 |
Effect of aspirin dose on hemocompatibility-related outcomes with a magnetically levitated left ventricular assist device: An analysis from the MOMENTUM 3 study
|
Saeed, Omar |
|
|
39 |
6 |
p. 518-525 |
artikel |
12 |
Enhanced functional recovery of the heart donated after circulatory death determination with antemortem heparin
|
Gao, Ling |
|
|
39 |
6 |
p. 607-609 |
artikel |
13 |
Felodipine and renal function in lung transplantation: A randomized placebo-controlled trial
|
Hornum, Mads |
|
|
39 |
6 |
p. 541-550 |
artikel |
14 |
Immune checkpoint inhibitors in heart or lung transplantation: Early results from a registry initiative
|
Daud, Anees |
|
|
39 |
6 |
p. 604-606 |
artikel |
15 |
Impact of left ventricular assist device implantation on mitral regurgitation: An analysis from the MOMENTUM 3 trial
|
Kanwar, Manreet K. |
|
|
39 |
6 |
p. 529-537 |
artikel |
16 |
Information for Readers
|
|
|
|
39 |
6 |
p. A2 |
artikel |
17 |
Is aspirin needed to prevent thrombotic events in patients treated with a HeartMate 3 left ventricular assist device?
|
Gustafsson, Finn |
|
|
39 |
6 |
p. 526-528 |
artikel |
18 |
Left ventricular assist systems and strokes: Statins to the rescue?
|
Patel, Jignesh K. |
|
|
39 |
6 |
p. 593-594 |
artikel |
19 |
Lung transplantation as standard of care for advanced cystic fibrosis lung disease
|
Benden, Christian |
|
|
39 |
6 |
p. 561-562 |
artikel |
20 |
Lung transplantation for cystic fibrosis
|
Yeung, Jonathan C. |
|
|
39 |
6 |
p. 553-560 |
artikel |
21 |
Pharmacological approaches to preserving renal function early after lung transplantation
|
Ahya, Vivek N. |
|
|
39 |
6 |
p. 551-552 |
artikel |
22 |
Regadenoson to the rescue: On the road toward prevention of primary graft dysfunction after lung transplantation
|
Shaver, Ciara M. |
|
|
39 |
6 |
p. 571-572 |
artikel |
23 |
Table of Contents
|
|
|
|
39 |
6 |
p. A3-A7 |
artikel |
24 |
The impact of statin therapy on neurological events following left ventricular assist system implantation in advanced heart failure
|
Vieira, Jefferson L. |
|
|
39 |
6 |
p. 582-592 |
artikel |
25 |
Understanding the impact of mitral regurgitation at the time of LVAD implantation
|
Pagani, Francis D. |
|
|
39 |
6 |
p. 538-540 |
artikel |